LOUISVILLE, KENTUCKY, UNITED STATES, March 11, 2024 /EINPresswire.com/ — Formosa Pharmaceuticals, Inc., Songshan Dist., Taipei City 105, Taiwan, announced the U.S. Food and Drug Administration (FDA) approved Clobetasol propionate ophthalmic suspension,…
Orasis Pharmaceuticals Announces FDA Approval of QLOSI™ (pilocarpine hydrochloride ophthalmic solution) 0.4% for the Treatment of Presbyopia Ponte Vedra, FL, October 18, 2023 QLOSI (pronounced CLOH-see) is a prescription eye…
For Immediate Release – July 25, 2023 Tarsus Pharmaceuticals, Inc, Irvine, CA, announced the U.S. Food and Drug Administration (FDA) has approved XDEMVY (lotilaner ophthalmic solution) 0.25% indicated for the…
We invite you to join a clinical trial evaluating an investigational eye drop for treating Presbyopia, an age-related condition making it difficult to see things up-close To participate in this…
Presbyopia Drop Study Are you having trouble seeing up close? A clinical research study is being conducted for adults who have trouble seeing nearby objects clearly due to presbyopia, or…